Food components and immune function

Current Opinion in Lipidology

Volumn 16, Issue 1, 2005, Pages 31-37

  Plat, Jogchum ^a   Mensink, Ronald P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Diet; Immune function; Inflammation

Indexed keywords

BETA GLUCAN; CURCUMIN; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINOLENIC ACID; OMEGA 3 FATTY ACID; POLYPHENOL; RESVERATROL; SATURATED FATTY ACID; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ANTIINFLAMMATORY ACTIVITY; BACTERIAL INFECTION; CYTOKINE PRODUCTION; DIETARY INTAKE; FAT INTAKE; FOOD COMPOSITION; GINKGO BILOBA; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFECTION RESISTANCE; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; REVIEW; TH1 CELL;

ANIMALIA; BACTERIA (MICROORGANISMS); GINGKO BILOBA; GINKGO (GENUS);

EID: 14744291559     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200502000-00007     Document Type: Review

References (63)

1. Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. 2nd ed. Philadelphia, PA: WB Saunders Company; 1994.
2. McHugh S, Deighton J, Rifkin I, et al. Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral mononuclear cells in primary culture. Eur J Immunol 1996; 26:1260-1265.
3. Beluzzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996; 334:1557-1560.
4. Palombella VJ, Rando OJ, Goldberg AL, et al. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 1994; 78:373-381.
5. Turpin P, Hay RT, Dargemont C. Characterization of IκBα nuclear import way. J Biol Chem 1999; 274:6804-6812.
6. Wu D. Modulation of immune and inflammatory responses by dietary lipids. Curr Opin Lipidol 2004; 15:43-47.
7. Bouic PJD, Etsebeth S, Liebenberg RW, et al. Beta sitosterol and beta-sitosterol glucoside stimulate human peripheral blood lymphocyte proliferation: implications for their use as an immunomodulatory vitamin combination. Int J Pharmacol 1996; 18:693-700.
8. Breytenbach U, Clark A, Lamprecht J, et al. Flow cytometric analysis of the Th1-Th2 balance in healthy individuals and patients infected with the human immunodeficiency virus (HIV) receiving plant sterol/sterolin mixture. Cell Biol Int 2001; 25:43-49.
9. Bouic PJD, Clark A, Lamprecht J, et al. The effects of b-sitosterol (BSS) and b-sitosterol glycoside (BSSG) mixture on selected immune parameters of marathon runners: inhibition of post marathon immune suppression and inflammation. Int J Sports Med 1999; 20:258-262.
10. Brown GD, Gordon S. Fungal β-glucans and mammalian immunity. Immunity 2003; 19:311-315. An excellent overview on the role of β-glucans and its receptors in innate immune responses.
11. Yun CH, Estrada A, van Kessel A, et al. β-Glucan, extracted from oat, enhances disease resistance against bacterial and parasitic infections. FEMS Immunol Med Microbiol 2003; 35:67-75. This paper elegantly illustrates that in mice resistance against both Staphylococcus aureus and Eimeria vermiformis infections was increased after intra-peritoneal and oral supplementation of oat-derived β-glucan supplementation.
12. Brown GD, Gordon S. A new receptor for β-glucans. Nature 2001; 413:36-37.
13. Brown GD, Taylor PR, Reid DM, et al. Dectin-1 is a major β-glucan receptor on macrophages. J Exp Med 2002; 196:407-412.
14. Herre J, Gordon S, Brown GD. Dectin-1 and its role in the recognition of β-glucans by macrophages. Mol Immunol 2004; 40:869-876. Excellent review on the identification of dectin-1 as the β-glucan receptor and its expression pattern throughout the body.
15. Young SH, Ye J, Frazer DG, et al. Molecular mechanism for tumor necrosis factor-alpha production in 1 → 3-beta-glucan (zymosan)-activated macrophages. J Biol Chem 2001; 276:20781-20787.
16. Gantner BN, Simmons RM, Canavera SJ, et al. Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2. J Exp Med 2003; 197:1107-1117. This study showed that dectin-1 enhanced the TLR-mediated activation of NF-κB synergistically. This demonstrates collaborative recognition of distinct microbial components by different classes of innate immune receptors.
17. Olsen NJ, Stein M. New drugs for rheumatoid arthritis. N Engl J Med 2004; 350:2167-2179.
18. Podolski DK. Inflammatory bowel disease. N Engl J Med 2002; 347:417-429.
19. Elliott MJ, Maini RN, Feldmann M, et al. Repeated therapy with monoclonal antibody to tumor necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 1994; 344:1125-1127.
20. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337:1029-1035.
21. Jobin C, Bradham CA, Russo MP, et al. Curcumin blocks cytokine mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor IκB kinase activity. J Immunol 1999; 163:3474-3483.
22. Poynter ME, Daynes RA. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 1998; 273:32833-32841.
23. Ricote M, Li AC, Willson TM, et al. The peroxisome proliferator activated receptor-γ is a negative regulator of macrophage activation. Nature 1998; 391:79-82.
24. Krey G, Braissant O, L'Horset F, et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997; 11:779-791.
25. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072:129-157.
26. Reiterer G, Toborek M, Henniog B. Peroxisome proliferator activated receptors α and γ require zinc for their anti-inflammatory properties in porcine vascular endothelial cells. J Nutr 2004; 134:1711-1715. This paper shows the importance of a good zinc status for PPAR signaling and the requirement of zinc for PPARα and PPAR agonists to exert antiinflammatory effects.
27. Santos MS, Lichtenstein AH, Leka LS, et al. Immunological effects of low-fat diets with and without weight loss. J Am Coll Nutr 2003; 22:174-182. This study showed that low-fat diets under conditions of weight-loss enhanced the cell-mediated immune response, as shown by a higher delayed type hypersensitivity response.
28. Meydani SN, Lichtenstein AH, Cornwall S, et al. Immunologic effects of national education panel step-2 diets with and without fish-derived n-3 fatty acid enrichment. J Clin Invest 1993; 92:105-113.
29. Kelley DS, Dougherty RM, Branch LB, et al. Concentration of dietary polyunsaturated fatty acids and the human immune status. Clin Immunol Immunopathol 1992; 62:240-244.
30. Luyer MD, Buurman WA, Hadfoune M, et al. Pretreatment with high-fat enteral nutrition reduces endotoxin and tumor necrosis factor alpha and preserves gut barrier function early after hemorrhagic shock. Shock 2004; 21:65-71. Rats were subjected to a nonlethal hemorrhagic shock, which normally results in loss of intestinal barrier function and bacterial translocation followed by proinflammatory response. High-fat pretreatment resulted in a lower translocation and a decrease in arterial TNFα concentrations.
31. Luyer MD, Jacobs JA, Vreugdenhil AC, et al. Enteral administration of high fat nutrition before and directly after hemorrhagic shock reduces endotoxemia and bacterial translocation. Ann Surg 2004; 239:257-264.
32. Lee JY, Zhao L, Youn HS, et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits toll-like receptor 2 dimirized with toll-like receptor 6 or 1. J Biol Chem 2004; 279:16971-16979. This paper states that the saturated fatty acid lauric acid - in contrast to the n-3 polyunsaturated DHA - directly activates TLRs, and consequently the transcription factor NF-κB. This finding indicates a potential mechanism by which n-3 fatty acids are antiinflammatory as compared with SAFAs.
33. Kitchens RL, Ulevitch RJ, Munford RS. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exp Med 1992; 176:485-494. 34 Qureshi N, Takayama K, Kurtz R. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect Immun 1991; 59:441-444.
34. James MJ, Proudman SM, Cleland LG. Dietary n-3 fatty acids as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis. Prostaglandins Leukot Essent Fatty Acids 2003; 68:399-405.
35. Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci 2004; 107:1-11.
36. Beluzzi A, Boschi S, Brignola C, et al. Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr 2000; 71:339s-342s.
37. Ford-Hutchinson AW, Bray MA, Doig MV, et al. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 287:264-265.
38. Alzoghaibi MA, Walsh SW, Willey A, et al. Linoleic acid but not oleic acid, upregulates the production of interleukin-8 by human intestinal smooth muscle cells isolated from patients with Crohn's disease. Clin Nutr 2003; 22:529-535.
39. Alzoghaibi MA, Walsh SW, Willey A, et al. Linoleic acid induced interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites. Am J Physiol Gastrointest Liver Physiol 2004; 286:G528-G537. It was found that one of the arachidonic acid metabolites produced by cyclooxygenase or lipoxygenase rather than linoleic acid itself was responsible for activating NF-κB and consequently IL-8 production.
40. Trebble TM, Arden NK, Wootton SA, et al. Peripheral blood mononuclear cell fatty acid composition and inflammatory mediator production in adult Crohn's disease. Clin Nutr 2004; 23:647-655.
41. Nishida T, Miwa H, Shigematsu A, et al. Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. Gut 1987; 28:1002-1007.
42. Pacheco S, Hillier K, Smith C. Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease. Clin Sci 1987; 73:361-364.
43. Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984; 86:453-460.
44. Sharon P, Ligumsky M, Rachmilewitz D, et al. Role of prostaglandins in ulcerative colitis: enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 1978; 75:638-640.
45. Lehmann JM, Lenhard JM, Oliver BB, et al. Peroxisome proliferator- activated receptor α and γ are activated by indomethacin and other non-steroidal antiinflammatory drugs. J Biol Chem 1997; 272:3406-3410.
46. Mishra A, Chaudhary A, Sethi S. Oxidized omega-3 fatty acids inhibit NF-κB activation via a PPARα-dependent pathway. Arterioscler Thromb Vasc Biol 2004; 24:1621-1627. This paper describes that not native, but particularly oxidized EPA and DHA, inhibited NF-κB activation and consequent IL-B and monocyte chemoattractant protein-1 production in endothelial cells. This effect was mediated by a PPARα-dependent pathway, as there were no effects of oxidized n-3 fatty acids oin PPARα-deficient mice.
47. Liu G, Bibus DM, Bode AM, et al. Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells. Proc Natl Acad Sci U S A 2001; 98:7510-7515.
48. de Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr 2000; 71:213s-223s.
49. Kew S, Mesa MD, Tricon S, et al. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr 2004; 79:674-681. Consumption of EPA (4.7 g/day) or DHA (4.9 g/day) for 4 weeks changed the fatty acid composition of plasma phospholipids and neutrophils as expected. Cytokine production or adhesion molecule expression on PBMCs was not changed. However, DHA lowered T-cell activation.
50. Kelley DS, Taylor PC, Nelson GJ, et al. Dietary docosahexanoic acid and immunocompetence in young healthy men. Lipids 1998; 33:559-566.
51. Kelley DS, Taylor PC, Nelson GJ, et al. Docosahexanoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 1999; 34:317-324.
52. Thies F, Nebe-von-Caron G, Powell JR, et al. Dietary supplementation with gamma-linoleic acid or fish oil decreases T-lymphocyte proliferation in healthy older humans. J Nutr 2001; 131:1918-1927.
53. Thies F, Nebe-von-Caron G, Powell JR, et al. Dietary supplementation with eicosapentanoic acid, but not with other long-chain n-3 or n-6 fatty acids, decreases natural killer cell activity in healthy subjects aged >55y. Am J Clin Nutr 2001; 73:539-548.
54. Radillis LS, Paschos G, Liakos GK, et al. Dietary α-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidemic patients. Atherosclerosis 2003; 167:237-242.
55. Kew S, Banerjee T, Minihana AM, et al. Lack of effect of foods enriched with plant- or marine-derived n-3 fatty acids on human immune function. Am J Clin Nutr 2003; 77:1287-1295. In this study no antiinflammatory effects of the plant-derived n-3 fatty acid α-linoleic acid were found. In contrast to several other studies, however, EPA and DHA were not effective either, making definite conclusions difficult.
56. Pendurthi UR, Williams JT, Rao LV. Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin: suppression of activation of tanscription factors Egr-1, AP-1, and NF-kappa B. Arterioscler Thromb Vasc Biol 1997; 17:3406-3413.
57. Chen JW, Chen YH, Lin FY, et al. Ginkgo biloba extract inhibits tumor necrosis factor-α-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23:1559-1566. Ginkgo biloba lowered TNFα-induced expression of VCAM and intercellular adhesion molecule on human arterial endothelial cells as well as formation of reactive oxygen species. These effects were ascribed to a lowered NF-κB and AP-1 activation.
58. Marcocci L, Maguire JJ, Droy-Lefaix MT, et al. The nitric oxide-scavenging properties of Ginkgo biloba extract Egb 761. Biochem Biophys Res Commun 1994; 201:748-755.
59. Carluccio MA, Siculella L, Ancora MA, et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation. Arterioscler Thromb Vasc Biol 2003; 23:622-629. This study showed that polyphenols from olive oil and red wine inhibited endothelial adhesion molecule expression. It was further demonstrated that both NF-κB and AP-1 were involved in this process.
60. Falchetti R, Fuggetta MP, Lanzilli G, et al. Effects of resveratrol on human immune cell function. Life Sci 2001; 70:81-96.
61. Bertelli AA, Giovannini L, Stradi R, et al. Kinetics of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after red wine oral administration in rats. Int J Clin Pharmacol Res 1996; 16:77-81.
62. Bertelli A, Bertelli AA, Gozzini A, et al. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp Clin Res 1998; 24:133-138.
63. Pellegatta F, Bertelli AA, Staels B, et al. Different short- and long-term effects of resveratrol on nuclear factor-κB phosphorylation and nuclear appearance in human endothelial cells. Am J Clin Nutr 2003; 77:1220-1228. At low concentrations of resveratrol (≤1.0 μM) acute NF-κB activation (30 min) was not affected, while overnight incubation increased activation of the NF-κB/IκB system in TNFα- stimulated endothelial cells.